IP Library › Granted Patent US 10,100,362
Granted Patent B2
US 10,100,362 · App. 14/853,987 · Granted Oct 16, 2018

Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof

Inventors: Hakon Hakonarson (Malvern, PA); Patrick Sleiman (Philadelphia, PA); Xiao Chang (Drexel Hill, PA)
Assignee: The Children's Hospital of Philadelphia
C12Q1/6883G01N33/5008G01N33/6803C12Q2600/106C12Q2600/156G01N2500/04G01N2500/10G01N2800/30G01N2800/302G01N2800/304
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,100,362
App. No.
14/853,987
Granted
Oct 16, 2018
Kind
B2
Abstract

Compositions and methods for the identification of agents useful for the treatment of neurological disorders, including schizophrenia, are provided.

Claims (6)

1. A method of treating schizophrenia (SCZ) or bi-polar (BP) disorder in a subject comprising:

a) obtaining genotype sequence information from nucleic acids obtained from a subject;

b) detecting in said information the presence of at least one SCZ or BP associated genetic alteration in NTRK3; and

c) treating the subject with at least one agent selected from ARRY470, ARRY872, AZ23, AZD6918, CE245677, DS6051, KT6587, LOXO101, PLX7486, RXDX101, and RXDX102.

2. The method of claim 1 , wherein the subject is treated with said at least one agent in combination with one or more additional agents selected from Serdolect, ABT126, ABT127, ABT925, Zoleptil, ABT354, Rexapin, Haloperidol lactate, Nuplazid, AM831, ACP104, Quetros, Aristab, Risperidone ACIS, Paxiprid, Loxapine succinate, Aripiprazole ,Zolafren, DA/5HT Modulator ADAMED, Kwetaplex, ADX63365, ADX50938, ADX71149, ATx11004, Cimicoxib Affectis, FazaClo, GlyT-1 inhibitor, Joykem, Alkepin, Ilopt, Invega Sustenna, Asenapine maleate AMNEAL, AG0098, APN1125, AVL3288, Apexidone, Clozapex, Ziprasidone Hydrochloride, Haloperidol decanoate, Apo-Clozapine, Apo-Pimozide, Ziprasidone Hydrochloride, Olanzapine ODF LABTEC, Dogmil, Zyprexa, Rispa, Amipride, Seronia, Seroquel, Huntexil, Zyprobiox, Fasoracetam, Risbiodal, Biopiprazole, Aripiprazole, Miradol, Fluphenazine decanoate, and Prochlorperazine edisylate.

3. The method of claim 1 , further comprising detecting a genetic alteration in at least one gene selected from neuromedin B, TSNARE1, MAD1L1, CACNA1D, NT5DC2, ITH1, NEK4 NIMA, GNL3, PB1, GLT8D1, FTSJ2, NUDT1, SNX8, SEC11A, SCAND2, ZSCAN2, ALPK3, PDE8A, GRIN2A, GRIN2B, DLG2, DLG1, DLG4, ATP2B2, NOS1, ERBB4, ANSK1B, CHUK, CNTN2, CNTNAP2, CUL3, CREB1, CREB5, EP300, GABBR2, GNA13, NCOR2, NTRK3, PAK2, PTK2, PTK2B, PTN, PTPRF, STK4, SEMA4C, PTPRG, MAPK8IP1, TIAM1, IRS1, and YWHAZ and TCF4.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2018
From: HAKONARSON, HAKON; SLEIMAN, PATRICK; CHANG, XIAO
To: THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Reel/Frame 045432/0638 →
Continuity (4)
Continuation In Part PCTUS2014028429 · Mar 14, 2014
Provisional Application 61785464 · Mar 14, 2013
Provisional Application 61788509 · Mar 15, 2013
Related Publication 20160032390A1 · Feb 4, 2016